{"organizations": [], "uuid": "ac3ec478888301be81547cdc0c18db34abd4138c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180424.html", "section_title": "Archive News &amp; Video for Tuesday, 24 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-moleculin-enters-agreement-with-bs/brief-moleculin-enters-agreement-with-bsp-pharmaceuticals-for-its-leukemia-drug-candidate-idUSFWN1S10YG", "country": "US", "domain_rank": 408, "title": "BRIEF-Moleculin Enters Agreement With BSP Pharmaceuticals For Its Leukemia Drug Candidate", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.997, "site_type": "news", "published": "2018-04-24T20:32:00.000+03:00", "replies_count": 0, "uuid": "ac3ec478888301be81547cdc0c18db34abd4138c"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-moleculin-enters-agreement-with-bs/brief-moleculin-enters-agreement-with-bsp-pharmaceuticals-for-its-leukemia-drug-candidate-idUSFWN1S10YG", "ord_in_thread": 0, "title": "BRIEF-Moleculin Enters Agreement With BSP Pharmaceuticals For Its Leukemia Drug Candidate", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "moleculin biotech inc", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "bsp pharmaceuticals s.p.a.", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " Moleculin Biotech Inc:\n* MOLECULIN ENTERS AGREEMENT WITH BSP PHARMACEUTICALS FOR ITS LEUKEMIA DRUG CANDIDATE\n* MOLECULIN BIOTECH INC - ENGAGED BSP PHARMACEUTICALS S.P.A. TO BEGIN PREPARATIONS FOR COMMERCIAL SCALE PRODUCTION OF ANNAMYCIN DRUG PRODUCT Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-24T20:32:00.000+03:00", "crawled": "2018-04-25T14:26:00.009+03:00", "highlightTitle": ""}